HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity.

Authors :: Schmidt M
Lehr HA
Almstedt K
Source :: Oncotarget [Oncotarget] 2024 Jun 20; Vol. 15, pp. 418-420. Date of Electronic Publication: 2024 Jun 20.
Publication Year :: 2024

Subjects :: Humans
Female
Prognosis
Biomarkers, Tumor metabolism
Biomarkers, Tumor genetics
Breast Neoplasms metabolism
Breast Neoplasms genetics
Breast Neoplasms pathology
Breast Neoplasms diagnosis
Receptor, ErbB-2 metabolism

Full Text Access

Tools